论文部分内容阅读
严重的高血压,是指舒张压持续高达或超过120mmHg。由于这类患者的病残率及死亡率均高于中等度或轻度高血压,放应及时治疗。本文研究采用舌下含服消心痛以迅速控制严重的未能控制的高血压之安全性与有效性。本研究采用双盲、随机的方式与安慰剂进行对照。共有19例患者参加本试验。其中11例含服消心痛,8例含服安慰剂。服药后2h 将所有患者分为3类:有反应为舒张压降至100mmHg 以下;无反应为舒张压下降不足10mmHg;部分反应为舒张压下降
Serious hypertension, refers to the diastolic blood pressure up to or exceeding 120mmHg. As these patients morbidity and mortality were higher than moderate or mild hypertension, should be timely treatment. This study investigates the safety and efficacy of subconjunctival oxytocin to rapidly control severe uncontrollable hypertension. This study was a double-blind, randomized, placebo-controlled trial. A total of 19 patients participated in the trial. Among them, 11 cases contained budesonide and 8 cases contained placebo. 2h after taking all patients were divided into three categories: a response to diastolic blood pressure dropped to 100mmHg less; no response to diastolic blood pressure less than 10mmHg; part of the response to diastolic blood pressure decreased